Volume 22, Number 3—March 2016
Research
Underestimation of Invasive Meningococcal Disease in Italy
Table 3
Type of sample | No. samples/no. tested (%) |
|||
---|---|---|---|---|
Positive by rPCR | Negative by rPCR | Not tested by rPCR | Total† | |
CSF | ||||
Culture positive | 33 | 0 | 0 | 33/90 (36.7) |
Culture negative | 55 | 2 | 0 | 57/90 (63.3) |
Not tested with culture | 72 | 0 | 0 | 0 |
Total |
160/162 (98.8) |
2/162 (1.2) |
0 |
0 |
Blood | ||||
Culture positive | 16 | 0 | 10 | 26/107 (24.3) |
Culture negative | 37 | 10 | 34 | 81/107 (75.7) |
Not tested with culture | 51 | 2 | 0 | 0 |
Total |
104/116 (89.7) |
12/116 (10.3) |
0 |
0 |
Total, CSF or blood | ||||
Culture positive | 49 | 0 | 10 | 59/197 (29.9) |
Culture negative | 92 | 12 | 34 | 138/197 (70.1) |
Not tested with culture | 123 | 2 | 0 | 0 |
Total | 264/278 (95.0) | 14/278 (5.0) | 0 | 0 |
*A total of 162 CSF samples were tested with rPCR, and 90 were tested with culture-based methods. A total of 116 blood samples were tested with rPCR, and 107 were tested with culture-based methods. CSF, cerebrospinal fluid; rPCR, real-time PCR.
†Proportion of samples that were positive, negative, or not tested with culture-based methods.
1These authors contributed equally to this article.
Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.